Exercise May Combat ‘Chemo Brain’: Study Highlights Cognitive Benefits for Cancer Patients

The mental fog many cancer patients describe during and after chemotherapy – often called “chemo brain” – may be mitigated with a simple intervention: structured exercise. A nationwide, multicenter study published in the Journal of the National Comprehensive Cancer Network suggests that a tailored exercise program, incorporating walking and resistance band exercises, can lessen cognitive impairment in patients undergoing chemotherapy, particularly those on a two-week treatment cycle.

For years, the prevailing advice for cancer patients undergoing treatment was often rest. However, a growing body of research, including findings from MD Anderson Cancer Center highlights the benefits of exercise during cancer treatment, demonstrates that physical activity can actually improve outcomes. This latest study builds on that evidence, focusing specifically on cognitive function.

The EXCAP Prescription and Study Design

The study, formally titled “Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled Trial,” involved 687 patients receiving chemotherapy for the first time at 20 community oncology practices across the United States. Participants were enrolled between 2009 and 2014 and did not have distant metastases; the majority were women and had undergone surgery and/or were being treated for breast cancer. Patients were randomly assigned to receive either an “exercise prescription” – dubbed EXCAP (Exercise for Cancer Patients) – alongside their usual chemotherapy, or to continue with chemotherapy alone.

EXCAP involved individualized walking and resistance band instructions, delivered using a “teach-back” method to ensure proper technique. Participants were asked to track their daily steps with a pedometer and record their resistance band activity in a daily diary. The program was designed to be accessible and home-based, removing barriers to participation.

Cognitive Benefits Tied to Treatment Schedule

The results revealed a significant benefit for patients receiving chemotherapy in two-week cycles. Those who adhered to the EXCAP prescription reported less overall cognitive decline, perceived cognitive impairment and mental fatigue compared to those who did not exercise. Interestingly, this benefit wasn’t as pronounced in patients on three- to four-week chemotherapy cycles. Researchers theorize that the shorter cycle may allow for sufficient recovery to benefit from the exercise program.

“It was striking to find that without a structured exercise plan, patients receiving chemotherapy often reduce their daily walking by half and experience notable increases in problems with thinking, memory, and mental fatigue,” explained co-lead author Po-Ju Lin, Ph.D., MPH, RD, of the Wilmot Cancer Institute at the University of Rochester Medical Center. The study showed that patients in the exercise group maintained their daily walking throughout chemotherapy, while those in the control group reduced their walking by 53%.

What Does ‘Chemo Brain’ Actually Mean?

The term “chemo brain” isn’t a formal medical diagnosis, but rather a common descriptor for a cluster of cognitive symptoms experienced by many cancer patients. These can include difficulties with memory, concentration, attention, and processing speed. The causes are complex and likely multifactorial, potentially involving inflammation, hormonal changes, fatigue, and the direct effects of chemotherapy on the brain. The National Foundation for Cancer Research emphasizes the importance of addressing these symptoms to improve quality of life.

Beyond Cognition: Broader Benefits of Exercise

This study focused on cognitive function, but the benefits of exercise for cancer patients extend far beyond. Research consistently demonstrates that regular physical activity can reduce cancer-related fatigue, improve strength and balance, boost mood, reduce anxiety and depression, support heart and lung health, and even potentially reduce the risk of cancer recurrence. As Karen Basen-Engquist, Ph.D., director of MD Anderson’s Center for Energy Balance in Cancer Prevention and Survivorship, notes, the science clearly shows that staying active during cancer treatment improves symptoms and side effects.

Limitations and Future Directions

While promising, the study has limitations. The patient population was largely comprised of women with breast cancer, limiting the generalizability of the findings to other cancer types and demographics. The study was conducted between 2009 and 2014, and treatment protocols may have evolved since then. The researchers acknowledge that chemotherapy can cause side effects like tiredness and nausea that make exercise difficult, and that the two-week cycle may be particularly conducive to benefiting from EXCAP.

Future research should explore the effectiveness of EXCAP in more diverse patient populations and across different chemotherapy regimens. Expanding on the patient population may further generalize these findings. Investigating the optimal intensity and duration of exercise, as well as the underlying mechanisms by which exercise protects cognitive function, are also important areas for future study.

Integrating Exercise into Cancer Care

The findings underscore the demand for cancer care providers to consider incorporating structured exercise prescriptions into routine chemotherapy care. As Lindsay L. Peterson, MD, MSCR, a medical oncologist at Washington University School of Medicine in St. Louis, commented, this study offers “encouraging news” that patients may be able to proactively reduce their risk of cognitive impairment during chemotherapy through exercise. The NCCN Guidelines for Survivorship already recommend routine physical activity for cancer survivors with cognitive dysfunction, emphasizing the importance of safety and providing detailed guidance on how to exercise safely.

Non-pharmacologic interventions like exercise, cognitive training, and mindfulness are particularly valuable because they are safe, accessible, and often low-cost, making them easier for patients to adopt compared to more expensive or clinic-based treatments.

What’s next? The researchers emphasize the importance of ongoing monitoring of cognitive and fatigue symptoms throughout treatment, and referral to exercise oncology specialists to tailor prescriptions to individual capabilities. This study provides a strong rationale for prioritizing exercise as a supportive care intervention for people undergoing chemotherapy, with the potential to preserve cognitive function and improve overall quality of life.